Fund Holdings — Commodore Capital LP

Total Portfolio Value:
$1.42B
Total Bought:
$334.90M
Total Sold:
$270.34M
Net Transaction:
+$64.56M
Notable People:
Michael Jonathan Kramarz, Robert Egen Turrell Atkinson, Commodore Capital Gp Llc
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V4,472,8403,525,000-947,840$188.26M$185.41M13.09%-$2.85M
Nuvalent Inc1,855,0001,375,000-480,000$131.56M$104.91M7.41%-$26.64M
Xenon Pharmaceuticals Inc.(XENE)2,325,0003,025,000+700,000$78.00M$94.68M6.68%+$16.68M
Enliven Therapeutics Inc4,675,0004,692,809+17,809$92.00M$94.14M6.64%+$2.13M
Agios Pharmaceuticals, Inc.(AGIO)2,185,0002,325,000+140,000$64.02M$77.33M5.46%+$13.31M
Celldex Therapeutics, Inc.(CLDX)3,200,0003,450,000+250,000$58.08M$70.21M4.96%+$12.13M
Alkermes plcSHS(ALKS)1,950,0002,450,000+500,000$64.39M$70.09M4.95%+$5.71M
Viridian Therapeutics, Inc.(VRDN)3,600,0004,875,000+1,275,000$48.53M$68.15M4.81%+$19.62M
Protagonist Therapeutics Inc01,075,000+1,075,000$0$59.42M4.19%+$59.42M
Cidara Therapeutics Inc01,175,000+1,175,000$0$57.23M4.04%+$57.23M
Scholar Rock Holding Corporation(SRRK)1,745,0001,450,000-295,000$56.10M$51.36M3.63%-$4.74M
Soleno Therapeutics Inc1,150,000610,000-540,000$82.17M$51.11M3.61%-$31.06M
Relay Therapeutics, Inc.(RLAY)013,350,000+13,350,000$0$46.19M3.26%+$46.19M
Nurix Therapeutics, Inc.(NRIX)3,978,9073,948,653-30,254$47.27M$44.98M3.17%-$2.29M
Centessa Pharmaceuticals PlcADS2,367,5783,298,289+930,711$34.05M$43.34M3.06%+$9.29M
Pharvaris N V
COM
1,911,4331,911,4330$30.01M$33.64M2.37%+$3.63M
Kymera Therapeutics, Inc.(KYMR)0750,000+750,000$0$32.73M2.31%+$32.73M
Mind Medicine Mindmed Inc4,525,0005,000,000+475,000$26.47M$32.45M2.29%+$5.98M
Spyre Therapeutics, Inc.(SYRE)1,988,0841,988,0840$32.08M$29.76M2.10%-$2.32M
Tyra Biosciences, Inc.(TYRA)950,0003,100,000+2,150,000$8.84M$29.67M2.09%+$20.83M
Vera Therapeutics, Inc.CL A(VERA)2,561,782800,000-1,761,782$61.53M$18.85M1.33%-$42.69M
CytomX Therapeutics, Inc.(CTMX)07,692,300+7,692,300$0$17.46M1.23%+$17.46M
Cogent Biosciences, Inc.(COGT)8,892,8162,311,164-6,581,652$53.27M$16.59M1.17%-$36.67M
Oruka Therapeutics, Inc.(ORKA)1,419,7141,419,7140$14.57M$15.91M1.12%+$1.35M
Bright Minds Biosciences Inc.(DRUG)500,000500,0000$18.04M$13.05M0.92%-$4.98M
Apogee Therapeutics Inc290,000290,0000$10.83M$12.59M0.89%+$1.76M
Inhibikase Therapeutics, Inc.(IKT)5,344,4325,397,488+53,056$11.70M$10.53M0.74%-$1.18M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.72M$7.96M0.56%+$240.0K
Tango Therapeutics, Inc.(TNGX)01,500,000+1,500,000$0$7.68M0.54%+$7.68M
Crescent Biopharma, Inc.(CBIO)0453,686+453,686$0$7.32M0.52%+$7.32M
Neurogene Inc.(NGNE)925,000427,866-497,134$10.83M$6.40M0.45%-$4.44M
Vistagen Therapeutics, Inc.(VTGN)1,575,0001,575,0000$3.94M$3.15M0.22%-$787.5K
Avalo Therapeutics, Inc.(AVTX)483,000483,0000$3.87M$2.41M0.17%-$1.46M
Cardiff Oncology, Inc.(CRDF)5,384,6160-5,384,616$16.91M$0—-$16.91M
Celcuity Inc.(CELC)695,6500-695,650$7.03M$0—-$7.03M
ORIC Pharmaceuticals, Inc.(ORIC)2,000,0000-2,000,000$11.16M$0—-$11.16M
Solid Biosciences Inc5,825,0000-5,825,000$21.55M$0—-$21.55M
Vaxcyte, Inc.(PCVX)1,650,0000-1,650,000$62.30M$0—-$62.30M
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q2 2025 | TickerTrail